Pulmonary manifestations in antiphospholipid syndrome

Autoimmunity Reviews

Volumn 5, Issue 5, 2006, Pages 344-348

  Stojanovich, Ljudmila ^a  

^a UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Adult respiratory distress syndrome; Antiphospholipid syndrome; Pulmonary manifestations; Pulmonary thromboembolism

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; CYCLOPHOSPHAMIDE; HEPARIN; HYDROCORTISONE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PHOSPHOLIPID ANTIBODY; PROSTACYCLIN; STEROID; WARFARIN;

ADULT RESPIRATORY DISTRESS SYNDROME; ANTICOAGULANT THERAPY; ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING DISORDER; CLINICAL FEATURE; DISEASE SEVERITY; DOCTOR PATIENT RELATION; ENDARTERECTOMY; FIBROSING ALVEOLITIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUNG ARTERY; LUNG DISEASE; LUNG EMBOLISM; LUNG HEMORRHAGE; LUNG INFARCTION; MATERNAL DISEASE; MICROTHROMBUS; PLASMAPHERESIS; POSTPARTUM SYNDROME; PULMONARY HYPERTENSION; REVIEW; THROMBOSIS;

ANTIPHOSPHOLIPID SYNDROME; HUMANS; HYPERTENSION, PULMONARY; PULMONARY EMBOLISM; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 33744987382     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2006.02.002     Document Type: Review

References (36)

1. Wilson W.A., Gharavi A.E., Koike T., Lockshin M.D., Branch D.W., Piette J.-C., et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42 (1999) 1309-1311
2. Espinosa G., Cervera R., Font J., and Asherson R.A. The lung in the antiphospholipid syndrome. Ann Rheum Dis 61 (2002) 195-198
3. Asherson R.A., and Cervera R. Review: antiphosphoslipid antibodies and the lung. J Rheumatol 22 (1995) 62-66
4. In: Asherson R.A., Cervera R., Piette J.C., and Shoenfeld Y. (Eds). The antiphospholipid syndrome II: autoimmune thrombosis (2002), ELSEVIER 1-457
5. Asherson R.A., and Cervera R. Review: antiphosphoslipid antibodies and the lung. J Rheumatol 22 (1995) 62-66
6. Asherson R.A., Mackworth-Young C.G., Boey M.L., Hull R.G., Saunders A., Gharavi A.E., et al. Pulmonary hypertension in systemic lupus erythematosus. BMJ 287 (1983) 1024-1025
7. Font J., López-Soto A., Cervera R., Balasch J., Pallarés L., Navarro M., et al. The "primary" antiphospholipid syndrome: antiphospholipid antibody pattern and clinical features of a series of 23 patients. Autoimmunity 9 (1991) 69-75
8. Espinosa G., Cervera R., Font J., et al. Cardiac and pulmonary manifestations in the antiphospholipid syndrome. The antiphospholipid syndrome II: autoimmune thrombosis (2002), Elservier Science B.V. 169-188
9. Alarcón-Segovia D., Deleze M., Oria C.V., Sánchez-Guerrero J., Gómez-Pacheco L., Cabiedes J., et al. Antiphospholipid antibodies and the antiphospholipid syndrome in systemic lupus erythematosus. A prospective analysis of 500 consecutive patients. Medicine (Baltimore) 68 (1989) 353-365
10. Miyata M., Suzuki K., Sakuma F., Watanabe H., Kaise S., Nishimaki T., et al. Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus. Int Arch Allergy Immunol 100 (1993) 351-354
11. Petri M., Rheinschmidt M., Whiting-O'Keefe Q., Hellmann D., and Corash L. The frequency of lupus anticoagulant in systemic lupus erythematosus. A study of sixty consecutive patients by activated partial thromboplastin time, Russell viper venom time, and anticardiolipin antibody level. Ann Intern Med 106 (1987) 524-531
12. Nagai H., Yasuma K., Katsuki T., Shimakura A., Usuda K., Nakamura Y., et al. Primary antiphospholipid syndrome and pulmonary hypertension with prolonged survival. A case report. Angiology 48 (1997) 183-187
13. Asherson R.A., Higenbottam T.W., Dinh Xuan A.T., Khamashta M.A., and Hughes G.R.V. Pulmonary hypertension in a lupus clinic: experience with twenty-four patients. J Rheumatol 17 (1990) 1292-1298
14. Chaouat A., Weitzenblum E., and Higenbottam T. The role of thrombosis in severe pulmonary hypertension. Eur Respir J 9 (1996) 356-363
15. Moser K.M., Auger W.F., Fedullo P.F., et al. Chronic majorvessel thromboembolic pulmonary hypertension. Circulation 81 (1990) 1735-1743
16. Cacoub P., Dorent R., Nataf P., Carayon A., Riquet M., Noe E., et al. Endothelin-1 in the lungs of patients with pulmonary hypertension. Cardiovasc Res 33 (1997) 196-200
17. Dingli D., Utz J.P., Krowka M.J., Ann L.O., and Tefferi A. Unexplained pulmonary hypertension in chronic myeloproliferative disorders. Chest 120 (2001) 801-808
18. Huaringa A.J., Tapia G.G., Darwish A., and Kornblau S.M. Myelofibrosis with myeloid metaplasia and antiphospholipid syndrome: coexistent etiologies of pulmonary hypertension and coagulation factor Ii and V deficiencies. Internet J Pulm Med 3 1 (2003)
19. Ware L.B., and Matthay M.A. The acute respiratory distress syndrome. N Engl J Med 342 (2000) 1334-1349
20. Ghosh S., Walters H.D., Joist J.H., Osborn T.G., and Moore T.L. Adult respiratory distress syndrome associated with antiphospholipid antibody syndrome. J Rheumatol 20 (1993) 1406-1408
21. Argento A., and DiBenedetto R.J. ARDS and adrenal insufficiency associated with the antiphospholipid antibody syndrome. Chest 113 (1998) 1136-1138
22. Asherson R.A., Cervera R., Piette J.C., Font J., Lie J.T., Burcoglu A., et al. Catastrophic antiphospholipid syndrome. Clinical and laboratory features of 50 patients. Medicine (Baltimore) 77 (1998) 195-207
23. Branch D.W., Kochenour N.K., Rok N.S., and Scott J.R. A new postpartum syndrome associated with antiphospholipid antibodies. Proceedings of the IInd International Symposium on Antiphospholipid Antibodies (1986), University of London, London 3-10
24. Kupferminc M.J., Lee M.J., Green D., and Peaceman A.M. Severe postpartum pulmonary, cardiac, and renal syndrome associated with antiphospholipid antibodies. Obstet Gynecol 83 (1994) 806-807
25. Kelion A.D., Cockcroft J.R., and Ritter J.M. Antiphospholipid syndrome in a patient with rapidly progressive fibrosing alveolitis. Postgrad Med J 71 (1995) 233-235
26. Sandoval J., Amigo M.C., Barragan R., et al. Primary antiphospholipid syndrome presenting as a chronic thromboembolic hypertension. Treatment with thromboendarterectomy. J Rheumatol 23 (1996) 772-775
27. Luchi M.E., Asherson R.A., and Lahita R.G. Primary idiopathic pulmonary hypertension complicated by pulmonary arterial thrombosis. Association with antiphospholipid antibodies. Arthritis Rheum 35 (1992) 700-705
28. Gertner E. Diffuse alveolar hemorrhage in the antiphospholipid syndrome: spectrum of the disease and treatment. J Rheumatol 26 (1999) 805-807
29. Specks U. Diffuse alveolar hemorrhage syndromes. Curr Opin Rheumatol 13 (2001) 12-17
30. Crausman R.S., Achenbach G.A., Pluss W.T., O'Brien R.F., and Jennings C.A. Pulmonary capillaritis and alveolar hemorrhage associated with the antiphospholipid antibody syndrome. J Rheumatol 22 (1995) 554-556
31. Asherson R.A., and Greenblat M.A. Recurrent alveolar hemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome. J Clin Rheumatol 7 (2001) 30-33
32. Muñoz-Rodríguez F.J., Font J., Cervera R., Reverter J.C., Tàssies D., Espinosa G., et al. Clinical study and follow-up of 100 patients with the antiphospholipid syndrome. Semin Arthritis Rheum 29 (1999) 182-190
33. Auger W.R., Permpikul P., and Moser K.M. Lupus anticoagulant, heparin use, and thrombocytopenia in patients with chronic thromboembolic pulmonary hypertension: a preliminary report. Am J Med 99 (1995) 392-396
34. Tam L.-S., and Li E.K. Successful treatment with immunosuppression, anticoagulation and vasodilator therapy of pulmonary hypertension in SLE associated with secondary antiphospholipid syndrome. Lupus 7 (1998) 495-497
35. Humbert M., Sanchez O., Fartoukh M., Jagot J.L., Sitbon O., and Simmonneau G. Treatment of severe pulmonary hypertension secondary to connective tissue diseases with continuous IV epoprostenol (prostacyclin). Chest 114 suppl 1 (1998) 80-82
36. Howe H.S., Boey M.L., Fong K.Y., and Feng P.H. Pulmonary haemorrhage, pulmonary infarction, and the lupus anticoagulant. Ann Rheum Dis 47 (1988) 869-872